Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
$11.91−0.54 (-4.34%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Mesoblast market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Mesoblast's market cap was $1.77B on Nov 11, 2026, against $2.08B a year earlier. Over the last 5 years it ranged from $136.88M to $2.18B, with a median of $578.62M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.77B | -18.9% |
| 2025 | Dec 31, 2025 | $2.18B | +11.5% |
| 2024 | Dec 31, 2024 | $1.95B | +1041.8% |
| 2023 | Dec 29, 2023 | $171.10M | -57.7% |
| 2022 | Dec 30, 2022 | $404.42M | -32.2% |
| 2021 | Dec 31, 2021 | $596.67M | -36.1% |
| 2020 | Dec 31, 2020 | $933.32M | +27.3% |
| 2019 | Dec 31, 2019 | $733.09M | +87.5% |
| 2018 | Dec 31, 2018 | $391.05M | -16.1% |
| 2017 | Dec 29, 2017 | $466.08M | +19.6% |
| 2016 | Dec 30, 2016 | $389.70M | – |
See a number that looks wrong?